Global regulators, industry leaders, scientists, and patient advocates set near-term commitments on early interception, trial modernization, and patient-first evidence. WASHINGTON, Sept. 11, 2025 ...
Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at Sanford Research (CoRDS), in partnership with Cure MITO, will contribute its mitochondrial disorders ...
Critical Path Institute ® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results